Skip to main content
padlock icon - secure page this page is secure

Why angiogenesis inhibition? Commentary.

Buy Article:

$42.00 + tax (Refund Policy)

Over the last several decades, cancer research and therapy have focused primarily on tumor cells. However, in 1971 it was proposed that a solid tumor cannot grow without recruiting endothelial cells. The hypothesis was that if one can block the formation of an adequate capillary network, tumor growth could be inhibited. Antiangiogenesis research is undoubtedly very fashionable today but compounds effective in clinical trials have not been reported so far. The goal of this commentary is to discuss two questions: what are the limitations of the old, established antitumor paradigm? Second, what are the advantages of the antiangiogenesis paradigm? At this time it is important to convince more scientists that the inhibition of angiogenesis is a valid concept against tumor growth. A stronger momentum of the antiangiogenesis movement will hopefully result in finding more effective compounds against cancer growth.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: Department of Surgical Research, Children's Hospital, Harvard Medical School, Ender's Research Building, Boston, MA 02115, USA.

Publication date: October 1, 1999

More about this publication?
  • The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.

    The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more